Autopsy report · NCT00800137

Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial

“At time of pre-specified 2nd interim analysis”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 4 years 3 months before it stopped.
• 984 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Ottawa Heart Institute Research Corporation

Sponsor type

University, hospital or other

Conditions

Hematoma

Interventions

low molecular weight heparin or unfractionated heparin; Warfarin or coumadin

Participants

984

Sites

22

Countries

Brazil, Canada

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.